Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NBIX |
---|---|---|
09:32 ET | 5253 | 140.335 |
09:34 ET | 400 | 139.67 |
09:36 ET | 486 | 139.67 |
09:38 ET | 428 | 140.004 |
09:39 ET | 100 | 139.99 |
09:41 ET | 2600 | 140.355 |
09:45 ET | 200 | 140.2 |
09:50 ET | 600 | 140.06 |
09:52 ET | 830 | 139.69 |
09:54 ET | 1700 | 139.94 |
09:56 ET | 394 | 140.2 |
09:57 ET | 855 | 140.15 |
09:59 ET | 450 | 139.94 |
10:01 ET | 1100 | 140.54 |
10:03 ET | 200 | 139.97 |
10:06 ET | 1007 | 139.77 |
10:08 ET | 1000 | 139.85 |
10:10 ET | 711 | 139.9001 |
10:12 ET | 1300 | 139.82 |
10:14 ET | 638 | 139.975 |
10:15 ET | 844 | 140.12 |
10:17 ET | 1223 | 140.26 |
10:19 ET | 1100 | 139.8 |
10:21 ET | 607 | 139.885 |
10:24 ET | 351 | 139.46 |
10:28 ET | 100 | 139.67 |
10:30 ET | 1000 | 139.655 |
10:32 ET | 600 | 139.31 |
10:33 ET | 479 | 139.33 |
10:35 ET | 1100 | 139.215 |
10:37 ET | 200 | 139.29 |
10:39 ET | 400 | 139.275 |
10:42 ET | 300 | 139.265 |
10:44 ET | 1700 | 139.16 |
10:46 ET | 2345 | 138.66 |
10:48 ET | 600 | 139.12 |
10:50 ET | 700 | 138.81 |
10:51 ET | 1400 | 138.745 |
10:53 ET | 1400 | 138.5 |
10:55 ET | 1500 | 138.9 |
10:57 ET | 1103 | 138.75 |
11:00 ET | 800 | 138.58 |
11:02 ET | 400 | 138.63 |
11:04 ET | 229 | 138.56 |
11:06 ET | 600 | 138.55 |
11:08 ET | 400 | 138.45 |
11:09 ET | 1225 | 138.34 |
11:11 ET | 600 | 138.29 |
11:13 ET | 600 | 138.29 |
11:15 ET | 1404 | 138.56 |
11:18 ET | 1515 | 138.4021 |
11:20 ET | 700 | 138.445 |
11:22 ET | 510 | 138.23 |
11:24 ET | 400 | 138.22 |
11:26 ET | 300 | 138.14 |
11:27 ET | 1730 | 138.04 |
11:29 ET | 400 | 138.235 |
11:31 ET | 4745 | 138.27 |
11:33 ET | 1800 | 138.12 |
11:36 ET | 200 | 138.29 |
11:38 ET | 843 | 138.19 |
11:40 ET | 1740 | 138.375 |
11:42 ET | 1868 | 138.09 |
11:44 ET | 1123 | 138.2 |
11:45 ET | 2367 | 138.07 |
11:47 ET | 4283 | 138.02 |
11:49 ET | 2464 | 137.74 |
11:51 ET | 700 | 137.78 |
11:54 ET | 1200 | 138.07 |
11:56 ET | 1000 | 137.74 |
11:58 ET | 980 | 137.71 |
12:00 ET | 4384 | 137.45 |
12:02 ET | 600 | 137.5 |
12:03 ET | 300 | 137.475 |
12:05 ET | 100 | 137.49 |
12:09 ET | 400 | 137.47 |
12:12 ET | 500 | 137.45 |
12:14 ET | 635 | 137.4399 |
12:16 ET | 2581 | 137.675 |
12:18 ET | 300 | 137.65 |
12:20 ET | 200 | 137.63 |
12:21 ET | 400 | 137.53 |
12:23 ET | 200 | 137.52 |
12:25 ET | 200 | 137.56 |
12:27 ET | 100 | 137.5 |
12:30 ET | 200 | 137.48 |
12:32 ET | 600 | 137.38 |
12:36 ET | 1100 | 137.37 |
12:38 ET | 650 | 137.295 |
12:39 ET | 1776 | 137.26 |
12:41 ET | 1320 | 137.505 |
12:43 ET | 350 | 137.42 |
12:45 ET | 1159 | 137.26 |
12:48 ET | 100 | 137.2 |
12:50 ET | 300 | 137.2 |
12:52 ET | 1294 | 137.38 |
12:54 ET | 200 | 137.37 |
12:56 ET | 300 | 137.34 |
12:57 ET | 1300 | 137.83 |
12:59 ET | 500 | 137.53 |
01:01 ET | 400 | 137.53 |
01:03 ET | 100 | 137.5 |
01:06 ET | 100 | 137.51 |
01:08 ET | 100 | 137.5 |
01:10 ET | 700 | 137.4 |
01:12 ET | 500 | 137.36 |
01:14 ET | 800 | 137.35 |
01:15 ET | 300 | 137.22 |
01:17 ET | 13507 | 137.46 |
01:19 ET | 1637 | 137.625 |
01:21 ET | 500 | 137.45 |
01:24 ET | 526 | 137.27 |
01:26 ET | 300 | 137.29 |
01:28 ET | 300 | 137.37 |
01:30 ET | 300 | 137.29 |
01:32 ET | 200 | 137.26 |
01:33 ET | 200 | 137.305 |
01:35 ET | 1549 | 137.2319 |
01:37 ET | 600 | 137.18 |
01:39 ET | 300 | 137.18 |
01:42 ET | 500 | 137.14 |
01:44 ET | 414 | 137.12 |
01:46 ET | 2100 | 136.88 |
01:48 ET | 200 | 136.88 |
01:50 ET | 200 | 136.8 |
01:51 ET | 200 | 136.97 |
01:53 ET | 100 | 136.81 |
01:55 ET | 551 | 136.955 |
01:57 ET | 505 | 136.84 |
02:00 ET | 1356 | 136.79 |
02:02 ET | 1031 | 136.63 |
02:04 ET | 400 | 136.6 |
02:06 ET | 1028 | 136.6125 |
02:08 ET | 4329 | 137.02 |
02:09 ET | 600 | 136.99 |
02:11 ET | 1550 | 136.95 |
02:13 ET | 1200 | 137 |
02:15 ET | 700 | 136.78 |
02:18 ET | 800 | 136.82 |
02:20 ET | 1594 | 136.64 |
02:22 ET | 800 | 136.59 |
02:24 ET | 300 | 136.63 |
02:26 ET | 1200 | 137.2 |
02:27 ET | 100 | 137.165 |
02:29 ET | 748 | 137.01 |
02:31 ET | 3564 | 136.735 |
02:33 ET | 904 | 136.78 |
02:36 ET | 700 | 136.56 |
02:38 ET | 300 | 136.55 |
02:40 ET | 100 | 136.59 |
02:42 ET | 1769 | 136.54 |
02:44 ET | 200 | 136.58 |
02:45 ET | 1100 | 136.73 |
02:47 ET | 400 | 136.68 |
02:49 ET | 1324 | 136.78 |
02:51 ET | 2104 | 136.75 |
02:54 ET | 1339 | 136.77 |
02:58 ET | 900 | 136.65 |
03:00 ET | 1200 | 136.53 |
03:02 ET | 400 | 136.51 |
03:03 ET | 300 | 136.62 |
03:05 ET | 806 | 136.59 |
03:07 ET | 700 | 136.55 |
03:09 ET | 2025 | 136.69 |
03:12 ET | 1620 | 136.59 |
03:14 ET | 1910 | 136.37 |
03:16 ET | 3783 | 136.36 |
03:18 ET | 2699 | 136.28 |
03:20 ET | 4075 | 136.19 |
03:21 ET | 4210 | 136.56 |
03:23 ET | 1969 | 136.505 |
03:25 ET | 400 | 136.47 |
03:27 ET | 700 | 136.65 |
03:30 ET | 2087 | 136.43 |
03:32 ET | 2129 | 136.37 |
03:34 ET | 980 | 136.55 |
03:36 ET | 1151 | 136.495 |
03:38 ET | 2189 | 136.6 |
03:39 ET | 1636 | 136.6 |
03:41 ET | 2115 | 136.61 |
03:43 ET | 3493 | 136.6 |
03:45 ET | 15853 | 136.75 |
03:48 ET | 1564 | 136.56 |
03:50 ET | 2900 | 136.8 |
03:52 ET | 6920 | 136.43 |
03:54 ET | 5126 | 136.57 |
03:56 ET | 17008 | 136.57 |
03:57 ET | 10960 | 136.74 |
03:59 ET | 20952 | 136.7 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Neurocrine Biosciences Inc | 13.8B | 37.6x | +62.04% |
Medpace Holdings Inc | 12.1B | 39.8x | +35.10% |
Qiagen NV | 9.7B | 28.6x | +12.66% |
United Therapeutics Corp | 11.7B | 12.5x | +8.22% |
Biomarin Pharmaceutical Inc | 15.4B | 76.7x | --- |
Sarepta Therapeutics Inc | 12.5B | 1,654.6x | --- |
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. The Company is focused on discovering and developing pharmaceuticals for the treatment of neurological, endocrine and psychiatric-based diseases and disorders. Its portfolio includes treatments for tardive dyskinesia, Parkinson’s disease, endometriosis and uterine fibroids. Its product pipeline includes INGREZZA (valbenazine), which provides a once-daily dosing treatment option for tardive dyskinesia and has three dosing options (40 milligrams (mg), 60 mg and 80 mg capsules); ONGENTYS (opicapone) is an adjunctive therapy to levodopa/carbidopa in patients with Parkinson’s disease; ORILISSA (elagolix) is used for the management of moderate to severe endometriosis pain in women. Its pipeline also includes DYSVAL (valbenazine), ORIAHNN (elagolix, estradiol, and norethindrone acetate and elagolix capsules), ALKINDI/ALKINDI SPRINKLE (hydrocortisone), and EFMODY (hydrocortisone modified-release hard capsules).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $13.8B |
---|---|
Revenue (TTM) | $2.0B |
Shares Outstanding | 100.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.36 |
EPS | $3.64 |
Book Value | $22.61 |
P/E Ratio | 37.6x |
Price/Sales (TTM) | 6.9 |
Price/Cash Flow (TTM) | 35.1x |
Operating Margin | 23.43% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.